Recursion Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Recursion Pharmaceuticals, Inc. (RXRX) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents0.590.390.550.290.26
Short-Term Investments0.000.000.000.230.00
Cash & Short-Term Investments0.590.390.550.520.26
Accounts Receivable0.050.000.000.000.00
Inventory0.000.000.000.000.00
Other Current Assets0.070.040.020.010.00
Total Current Assets0.710.440.570.530.27
Non-Current Assets
Property, Plant & Equipment (Net)0.230.120.120.060.03
Long-Term Investments0.010.000.000.000.00
Goodwill0.150.050.000.000.00
Intangible Assets0.340.040.000.000.00
Other Non-Current Assets0.010.010.010.010.00
Total Non-Current Assets0.730.220.130.080.00
Total Assets1.450.650.700.610.30
Current Liabilities
Accounts Payable0.020.050.000.000.00
Short-Term Debt0.000.000.000.000.00
Current Portion of Long-Term Debt0.000.000.000.000.00
Accrued Liabilities0.080.040.030.020.01
Deferred Revenue0.060.040.060.010.01
Other Current Liabilities0.000.020.000.000.00
Total Current Liabilities0.190.090.100.050.02
Non-Current Liabilities
Long-Term Debt0.000.040.000.000.01
Deferred Tax Liabilities0.020.000.000.000.00
Other Non-Current Liabilities0.000.000.000.010.01
Total Non-Current Liabilities0.230.100.120.020.00
Total Liabilities0.410.190.220.070.06
Stockholders' Equity
Common Stock0.000.000.000.000.00
Retained Earnings-1.43-0.97-0.64-0.40-0.21
Accumulated Other Comprehensive Income-0.010.000.000.000.00
Additional Paid-in Capital2.471.431.130.940.00
Shares Outstanding0.400.230.190.170.00
Total Stockholders' Equity1.030.460.490.540.24
Total Liabilities & Equity1.450.650.700.610.00